WATSON 607 (Labetalol 300 mg)

Pill imprint WATSON 607 has been identified as Labetalol hydrochloride 300 mg.

Labetalol is used in the treatment of hypertensive emergency; high blood pressure; pheochromocytoma; postural orthostatic tachycardia syndrome; mitral valve prolapse and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Labetalol 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Labetalol hydrochloride

Imprint:

WATSON 607

Strength:

300 mg

Color:

Blue

Size:

11.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Non-cardioselective beta blockers

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

00591-0607

Inactive Ingredients:

lactose anhydrous
silicon dioxide colloidal
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
corn starch
water
titanium dioxide
FD&C Blue No. 2
aluminum oxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
00904-5930	Major Pharmaceuticals
68084-0457	Amerisource Health Services
60429-0279	Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.